WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H123922
CAS#: 958843-91-9
Description: CMLD-2 is an inhibitor of HuR-ARE interaction.
Hodoodo Cat#: H123922
Name: CMLD-2
CAS#: 958843-91-9
Chemical Formula: C31H31NO6
Exact Mass: 513.22
Molecular Weight: 513.590
Elemental Analysis: C, 72.50; H, 6.08; N, 2.73; O, 18.69
Synonym: 958843-91-9; CMLD-2; MLS000879470; SMR000465530; CMLD2; CMLD 2
IUPAC/Chemical Name: 5,7-dimethoxy-8-(1-(4-methoxyphenyl)-3-oxo-3-(pyrrolidin-1-yl)propyl)-4-phenyl-2H-chromen-2-one
InChi Key: PROGRNRRJJYCNX-UHFFFAOYSA-N
InChi Code: InChI=1S/C31H31NO6/c1-35-22-13-11-21(12-14-22)23(17-27(33)32-15-7-8-16-32)29-25(36-2)19-26(37-3)30-24(18-28(34)38-31(29)30)20-9-5-4-6-10-20/h4-6,9-14,18-19,23H,7-8,15-17H2,1-3H3
SMILES Code: O=C1C=C(C2=CC=CC=C2)C3=C(OC)C=C(OC)C(C(C4=CC=C(OC)C=C4)CC(N5CCCC5)=O)=C3O1
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 513.59 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Allegri L, Baldan F, Roy S, Aubé J, Russo D, Filetti S, Damante G. The HuR
CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid
cancer cells. Sci Rep. 2019 May 14;9(1):7374. doi: 10.1038/s41598-019-43894-0.
PMID: 31089242; PMCID: PMC6517587.
2: Muralidharan R, Mehta M, Ahmed R, Roy S, Xu L, Aubé J, Chen A, Zhao YD,
Herman T, Ramesh R, Munshi A. HuR-targeted small molecule inhibitor exhibits
cytotoxicity towards human lung cancer cells. Sci Rep. 2017 Aug 30;7(1):9694.
doi: 10.1038/s41598-017-07787-4. PMID: 28855578; PMCID: PMC5577245.
3: Kunder N, de la Peña JB, Lou TF, Chase R, Suresh P, Lawson J, Shukla T, Black
B, Campbell ZT. The RNA-Binding Protein HuR Is Integral to the Function of
Nociceptors in Mice and Humans. J Neurosci. 2022 Dec 7;42(49):9129-9141. doi:
10.1523/JNEUROSCI.1630-22.2022. Epub 2022 Oct 21. PMID: 36270801; PMCID:
PMC9761683.